Dr. Ari Melnick and colleagues have published breakthrough findings that show certain histone H1 mutations are drivers of lymphoma.
The award provides early-career scientists with $500,000 over five years to investigate the interplay between humans and pathogens, and how such encounters can lead to disease.
The award, which will support Dr. Rafii’s project to accelerate regenerative medicine technology, provides $1 million per year (including direct and indirect costs) for seven years.
Published in the Journal of the American College of Cardiology, Drs. Jonathan Weinsaft and Jiwon Kim have shown that an echocardiogram is a useful tool in evaluating COVID-19 patients who have damage to the heart’s right ventricle.
Dr. Brad Jones, Division of Infectious Diseases, began a collaboration several years ago involving T-cell therapy approaches to HIV that has played a key role in a breakthrough study on COVID-19.
Dr. Gregory F. Sonnenberg has been recognized for his “innovative research program which continues to make seminal scientific contributions at the interface of immunology and microbiology.”
A team of intercampus investigators has received a $3.65 million grant from the NIH to develop an inexpensive method for accurately diagnosing UTIs in kidney transplant patients by carrying out molecular profiling of cell-free DNA in urine.
In this paper, which reflected further analysis stemming from their previous paper published in Nature Communications (December 2019), 168 kidney transplant recipients, who provided 510 fecal specimens, were evaluated.
The Research Retreat will provide a distinct forum to bring together a diverse range of established and emerging faculty and trainees and experts in complimentary fields to foster and expand research efforts in the Weill Department of Medicine.
Investigators at Weill Cornell Medicine and NewYork-Presbyterian are recruiting 1,000 asymptomatic health care workers for a study on COVID-19 that seeks to answer the question: why do some people become severely ill, while others have no symptoms?
